Axovant Sciences (AXON) Priced

Newly formed biotech developing a late-stage Alzheimer's therapy acquired from GSK.

Health Care - Biotechnology

IPO Performance
Latest Trade $12.10 -0.05 (-0.4%)
First Day Return 99.3%
Return from IPO -19.1%
 
Axovant Sciences IPO News more
  • .
IPO Data
IPO File Date 05/11/2015
Offer Price $15.00
Price Range $13.00 - $15.00
Offer Shares (mm) 21.0
Deal Size ($mm) 315
 
IPO Data
IPO Date 06/10/2015
Offer Price $15.00
Price Range $13.00 - $15.00
Offer Shares (mm) 21.0
Deal Size ($mm) $315
 
Underwriters
more
Business Overview
Newly formed biotech developing a late-stage Alzheimer's therapy acquired from GSK.
Newly formed biotech developing a late-stage Alzheimer's therapy acquired from GSK.
more
Company Data
Headquarters Hamilton, , Bermuda
Founded 2014
Employees 8
Website www.axovant.com
 

Performance vs. IPO Index (IPOUSA)